Regado Slashes Price To Complete Offering Amidst A Mixed IPO Field
This article was originally published in The Pink Sheet Daily
Executive Summary
The New Jersey-based anticoagulant developer cut its share price by roughly two-thirds, but offered more shares to compensate. It’s a big haircut, during a period when some other offerings are exceeding expectations.